Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback